Table 2. Characteristics at Referral in... | American Society of Hematology

Table 2.

Characteristics at Referral in Patients With and Without Eventual Transformation

Characteristic	No. of Patients	No. With Transformation	P Value^*
Age
<60 yr	60	11	.25
≥60 yr	55	15
Sex
Male	65	13	.48
Female	50	13
Stage
I-II v	78	18	.94
III-IV	37	8
I-IIA v	58	8	.03
IIB-IV	57	18
T staging
T1	36	0	.000005
T2	24	8
T3	28	13
T4	27	5
β2M (mg/L)
Low (≤2)	54	11	.080
High (>2)	38	14
LDH (U/L)
Low	74	16	.52
High^†	37	10
LDH + β2M^‡
No v	46	7	.009
1 and/or 2	46	18
Lymph node involvement
No	79	16	.37
Yes	36	10
Peripheral blood involvement
No	93	21	.95
Yes	22	5
Bone marrow involvement
No	108	25	.95
Yes	7	1

Characteristic	No. of Patients	No. With Transformation	P Value^*
Age
<60 yr	60	11	.25
≥60 yr	55	15
Sex
Male	65	13	.48
Female	50	13
Stage
I-II v	78	18	.94
III-IV	37	8
I-IIA v	58	8	.03
IIB-IV	57	18
T staging
T1	36	0	.000005
T2	24	8
T3	28	13
T4	27	5
β2M (mg/L)
Low (≤2)	54	11	.080
High (>2)	38	14
LDH (U/L)
Low	74	16	.52
High^†	37	10
LDH + β2M^‡
No v	46	7	.009
1 and/or 2	46	18
Lymph node involvement
No	79	16	.37
Yes	36	10
Peripheral blood involvement
No	93	21	.95
Yes	22	5
Bone marrow involvement
No	108	25	.95
Yes	7	1

Abbreviations: N/E, not evaluable; T1, limited patch/plaque (<10% of total skin surface); T2, generalized patch/plaque (≥10% of total skin surface); T3, tumors; T4, generalized erythroderma.

By χ² or Fisher exact test, as appropriate.

†

≥10% above the upper limit of the normal range.

‡

No elevation of LDH or β2M versus elevation of LDH and/or β2M.

View Large

This Feature Is Available To Subscribers Only